Proteome Sciences plc
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PMSNF research report →
Price Chart
About the company
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant that provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator which analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids. It also offers top 14 and top 65 super depletion of proteins from serum and plasma; selective reaction monitoring (SRM) and parallel reaction monitoring (PRM) based biomarker assay development; SRM assay, a targeted mass spectrometry assay format for the routine measurement of biomarkers; and TMT SRM, a targeted assay format that enables the rapid validation of biomarker candidates.
- CEO
- Anil Wadhwani
- IPO
- 2010
- Employees
- 32
- HQ
- Cobham, SU, GB
Get TickerSpark's AI analysis on PMSNF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $2.89M
- P/E
- -1.33
- PEG
- -0.03
- P/S
- 0.90
- P/B
- -0.34
- EV/EBITDA
- -14.08
- Div Yield
- 0.00%
- Gross Margin
- -25.36%
- Op Margin
- -60.56%
- Net Margin
- -61.46%
- ROE
- 23.85%
- ROIC
- -25.45%
Latest fiscal year · YoY change
- Revenue
- $3.76M-23.1%
- Gross Profit
- $-1,006,836-503.1%
- Op Income
- $-2,624,574
- Net Income
- $-3,060,503+10.1%
- EPS
- $-0.01+9.6%
- OCF Growth
- +94.4%
- FCF Growth
- +86.4%
- 52W High
- $0.04
- 52W Low
- $0.01
- 50D MA
- $0.01
- 200D MA
- $0.02
- Beta
- 0.15
- RSI (14)
- 45
- Avg Volume
- 229
No earnings-call transcripts are available for PMSNF yet.
- Free Float
- 76.7%
- Shares Outstanding
- 288.92M
- Float Shares
- 221.68M
Our PMSNF coverage
Recent articles, reports, and earnings notes.
No research on PMSNF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PMSNF report →